Effects of combination chemotherapy on immunoregulatory cells in peripheral blood of solid tumor cancer patients: correlation with rebound overshoot immune function recovery.
D000328:Adult; D000368:Aged; D006585:Altretamine / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002448:Cell Adhesion; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007213:Indomethacin / Q000494:pharmacology; D002955:Leucovorin / Q000627:therapeutic use; D008213:Lymphocyte Activation; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D008937:Mitomycins / Q000627:therapeutic use; D009000:Monocytes / Q000276:immunology*; D009369:Neoplasms / Q000188:drug therapy*; D010835:Phytohemagglutinins / Q000494:pharmacology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013997:Time Factors
D000970:Antineoplastic Agents; D008937:Mitomycins; D010835:Phytohemagglutinins; D002955:Leucovorin; D006585:Altretamine; D005472:Fluorouracil; D007213:Indomethacin; D008727:Methotrexate